Novel Fluoropyrimidines: Improving the Efficacy and Tolerability of Cytotoxic Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|4|2|191-204

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.4, Iss.2, 2004-03, pp. : 191-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination Nicotine Replacement Therapy for Smoking Cessation: Rationale, Efficacy and Tolerability

By Sweeney C.T.  

CNS Drugs, Vol. 15, Iss. 6, 2001-01 ,pp. : 453-467

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Cisapride in Children

By Vandenplas Y.   Benatar A.   Cools F.   Arana A.   Hegar B.   Hauser B.  

Pediatric Drugs, Vol. 3, Iss. 8, 2001-01 ,pp. : 559-573

Adis International

Access to resources Recommend Favorite

Novel Non-Cytotoxic Therapy in Ovarian Cancer: Current Status and Future Prospects

By Martin Lainie   Schilder Russell J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 9, 2006-10 ,pp. : 955-966

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Efficacy and Tolerability of 5- vs 10-Day Cefixime Therapy in Acute Exacerbations of Chronic Bronchitis

By Lorenz J.  

Clinical Drug Investigation, Vol. 15, Iss. 1, 1998-01 ,pp. : 13-20

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Sequential Intravenous/Oral Moxifloxacin Therapy in Pneumonia: Results of the First Post-Marketing Surveillance Study with Intravenous Moxifloxacin in Hospital Practice

By Barth J.  

Clinical Drug Investigation, Vol. 25, Iss. 11, 2005-01 ,pp. : 691-700

Adis International

Access to resources Recommend Favorite